The SEQUENCE Trial
Recruiting · NCT06676956 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Linear EBUS firstRobotic-assisted bronchoscopy first
What this trial is about
This study will randomize participants undergoing a bronchoscopic biopsy of a peripheral pulmonary nodule for their standard of care to receive robotic-assisted bronchoscopy (RaB) and then staging linear endobronchial ultrasounnd (EBUS) OR staging linear EBUS first, followed by RaB. The goal of this study is to set the standard for optimizing the sequence of bronchoscopic procedures in patients at risk for early-stage malignancy.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Peripheral Pulmonary Nodule undergoing a robotic-assisted bronchoscopy
Exclusion criteria
- lymph nodes that are enlarged or PET avid on CT prior to procedure
Where it is running
5 locations listed across 5 US states.
- University of California, Davis - Sacramento, California, United States
- Northwestern University - Chicago, Illinois, United States
- Johns Hopkins University - Baltimore, Maryland, United States
- University of Michigan - Ann Arbor, Michigan, United States
- University of North Carolina, Chapel Hill - Chapel Hill, North Carolina, United States